Tokyo Tape
Sign in
← Muromachi Chemicals

Quarterly report · Q3

4885.TEDINET S100QLE5
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
MetricValuePeriodScopeSource row
Revenue¥4.6bn2022-06-01 → 2023-02-28StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31StandaloneNet sales (5-year summary)
Revenue¥4.1bn2021-06-01 → 2022-02-28StandaloneNet sales
Operating income¥325m2022-06-01 → 2023-02-28StandaloneOperating income
Operating income¥355m2021-06-01 → 2022-02-28StandaloneOperating income
Ordinary income¥309m2022-06-01 → 2023-02-28StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥355m2021-06-01 → 2022-02-28StandaloneOrdinary income
Profit before tax¥309m2022-06-01 → 2023-02-28StandaloneIncome before income taxes
Profit before tax¥354m2021-06-01 → 2022-02-28StandaloneIncome before income taxes
Net income¥230m2022-06-01 → 2023-02-28StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31StandaloneNet income loss (5-year summary)
Net income¥300m2021-06-01 → 2022-02-28StandaloneProfit loss
Total assets¥5.0bnat 2023-02-28StandaloneAssets
Total assets¥4.8bnat 2022-05-31StandaloneAssets
Total assets¥4.6bnat 2022-02-28StandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2023-02-28StandaloneLiabilities
Total liabilities¥3.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥1.9bnat 2023-02-28StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.6bnat 2022-02-28StandaloneNet assets (5-year summary)
Cash and deposits¥681mat 2023-02-28StandaloneCash and deposits
Cash and deposits¥865mat 2022-05-31StandaloneCash and deposits
EPS (basic)¥61.462022-06-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥21.532022-12-01 → 2023-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥81.552021-06-01 → 2022-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥10.262021-12-01 → 2022-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥58.552022-06-01 → 2023-02-28StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥73.622021-06-01 → 2022-02-28StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio37.5%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.2%at 2022-02-28StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2023-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-02-28StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥25m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥75m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥426m
—segment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥325m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥325m
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥1.4bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥1.4bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2021-06-01 → 2022-02-28−¥2m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥668m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥668m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥22m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥335m
—segment totalrevenue2021-06-01 → 2022-02-28¥4.1bn
—segment totalrevenue external2021-06-01 → 2022-02-28¥4.1bn
—segment totalsegment profit2021-06-01 → 2022-02-28¥355m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥4.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥355m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人ト　ー　マ　ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese) 増　　村　　正　　之
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese) 宮　　嵜　　　 健
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration_NonConsolidatedMember4087743000JPY
Net sales (5-year summary)CurrentYTDDuration_NonConsolidatedMember4624606000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember5681099000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember354739000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember308576000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember423041000JPY
Net income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember299737000JPY
Net income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember230175000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember456272000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYTDDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior1QuarterInstant_NonConsolidatedMember143172000JPY
Capital stock (5-year summary)CurrentQuarterInstant_NonConsolidatedMember143172000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember143172000JPY
Total number of issued shares (5-year summary)Prior1QuarterInstant_NonConsolidatedMember4095500
Total number of issued shares (5-year summary)CurrentQuarterInstant_NonConsolidatedMember4095500
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember4095500
Net assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember1600684000JPY
Net assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1871123000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember1681080000JPY
Total assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember4553479000JPY
Total assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember4993241000JPY
Total assets (5-year summary)Prior1YearInstant_NonConsolidatedMember4798071000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember81.55
Basic earnings loss per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember61.46
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember123.79
Diluted earnings per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember73.62
Diluted earnings per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember58.55
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember112.56
Dividend paid per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember－
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember19.00
Equity to asset ratio (5-year summary)Prior1QuarterInstant_NonConsolidatedMember0.352
Equity to asset ratio (5-year summary)CurrentQuarterInstant_NonConsolidatedMember0.375
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.350
Basic earnings loss per share (5-year summary)Prior1QuarterDuration_NonConsolidatedMember10.26
Basic earnings loss per share (5-year summary)CurrentQuarterDuration_NonConsolidatedMember21.53
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember4095500
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember4095500
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant4095500
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant4095500
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · revenuenon_consolidated 2021-06-01/2022-02-28pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2023-02-28pass